Age and cellular composition influence overall survival in a collective of non-immunocompromised patients with EBV-positive diffuse large B-cell lymphoma from a German lymphoma center.

about

Response and survival benefit with chemoimmunotherapy in Epstein-Barr virus-positive diffuse large B-cell lymphoma.

P2860

Q40150053-428B6DD4-D0E3-473B-BD2D-1791B8CBEFD8

P2860

Age and cellular composition influence overall survival in a collective of non-immunocompromised patients with EBV-positive diffuse large B-cell lymphoma from a German lymphoma center.

Item

http://www.wikidata.org/entity/Q40696036

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Age and cellular composition i ...... from a German lymphoma center.

@en

type

Item

label

Age and cellular composition i ...... from a German lymphoma center.

@en

prefLabel

Age and cellular composition i ...... from a German lymphoma center.

@en

P1476

Age and cellular composition i ...... from a German lymphoma center.

@en

P2093

Dido Lenze

http://www.w3.org/2001/XMLSchema#string

Ioannis Anagnostopoulos

http://www.w3.org/2001/XMLSchema#string

Korinna Jöhrens

http://www.w3.org/2001/XMLSchema#string

Marita Ziepert

http://www.w3.org/2001/XMLSchema#string

Ralf Ulrich Trappe

http://www.w3.org/2001/XMLSchema#string

P2860

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma

Prevalence and clinical implications of epstein-barr virus infection in de novo diffuse large B-cell lymphoma in Western countries.

A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas.

Lymphomas differ in their dependence on Epstein-Barr virus

Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab.

Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60).

Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.

Rescue of "crippled" germinal center B cells from apoptosis by Epstein-Barr virus.

P304

2791-2803

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/10428194.2016.1169406

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Michael Pfreundschuh

Michael Hummel

P577

2016-04-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27122390

http://www.w3.org/2001/XMLSchema#string

Age and cellular composition influence overall survival in a collective of non-immunocompromised patients with EBV-positive diffuse large B-cell lymphoma from a German lymphoma center.

about

P2860

P2860

Age and cellular composition influence overall survival in a collective of non-immunocompromised patients with EBV-positive diffuse large B-cell lymphoma from a German lymphoma center.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698